The Exercise for the Prevention of Falls in Older Adults with Sarcopenic Obesity Pilot Study (ESPRESSO-P).

Not Applicable

Recruiting

• Conditions: Injuries and Accidents - Other injuries and accidents; Sarcopenic Obesity; Falls Risk; Musculoskeletal - Other muscular and skeletal disorders; Diet and Nutrition - Obesity

• Registration Number: ACTRN12618000192280
• Lead Sponsor: Dr. David Scott

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-07
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Prospective participants must be aged 60 years or older; have a body fat percentage more than or equal to 30 (men) or more than or equal to 40 (women); a Short Physical Performance Battery (SPPB) score less than or equal to 11 out of 12; willing, and has GP approval to complete a 24-week exercise intervention; and also be willing to participate should they be randomised to either intervention arm.

Exclusion Criteria

Participants are ineligible if they currently reside in a nursing home; are unable to walk 400m in 15 minutes without use of walking aids; are non-English speaking or have difficulty communicating with study personnel due to speech or hearing problems; have moderate or severe cognitive impairment defined as a Mini-Mental State Exam (MMSE) score less than or equal to 18 points out of 30; report consuming more than 14 alcoholic drinks per week; report more than or equal to 4 weeks self-reported participation in a supervised exercise program targeted at weight loss or strength gains in the past six months; are planning to be away from home for more than or equal to 4 weeks during the intervention; and self-reported diagnosis of: progressive neurological disorders including Parkinson's Disease and multiple sclerosis; schizophrenia or bipolar disorder; severe knee or hip osteoarthritis (awaiting a joint replacement) that would interfere with ability to complete functional tests; cardiovascular disease (including NYHA Class III or IV congestive heart failure, clinically significant valvular disease, history of cardiac arrest, presence of an implantable cardiac defibrillator, or uncontrolled angina); lung disease requiring regular use of corticosteroids or supplemental oxygen; renal disease requiring dialysis; and any other disorder of such severity that life expectancy is less than 12 months. Temporary exclusion criteria will include hip or knee replacement, spinal surgery, stroke, myocardial infarction, major heart surgery, deep vein thrombosis, or pulmonary embolus in the past 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified